Search Within

Joachim Yahalom

  1. "Breast Medicine Service"
Formats
  1. Journal Article (5)
  2. Meeting Abstract (5)
Groups
  1. Breast Medicine Service (10)
  2. Department of Medicine (10)
  3. Radiation Oncology, Department of (10)
  4. Solid Tumor Oncology Division (10)
  5. Survivorship Research (10)
  6. Center for Hematologic Malignancies (8)

More Groups

People
  1. Andrew Zelenetz (8)
  2. David Straus (8)
  3. Alison Moskowitz (7)
  4. Anita Kumar (7)
  5. Ariela Noy (7)
  6. Heiko Schoder (7)

More People

Years
  1. 2022 (1)
  2. 2021 (1)
  3. 2019 (1)
  4. 2017 (2)
  5. 2016 (1)
  6. 2014 (1)

More Years

Publications
  1. Blood (5)
  2. Annals of Oncology (1)
  3. Clinical Cancer Research (1)
  4. Hematological Oncology (1)
  5. Journal of Clinical Oncology (1)
  6. The Cancer Journal from Scientific American (1)
Publishers
  1. American Society of Hematology (5)
  2. American Association for Cancer Research (1)
  3. American Society of Clinical Oncology (1)
  4. Oxford University Press (1)
  5. Scientific American (1)
  6. Wiley Blackwell (1)

Results (10)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Brentuximab vedotin combined with chemotherapy in newly diagnosed, early-stage, unfavorable-risk Hodgkin lymphoma: Extended follow-up with evaluation of baseline metabolic tumor volume and PET2
    Meeting Abstract

    Stuver, R.; Michaud, L.; Casulo, C.; Advani, R. H.; Budde, E. L.; Barr, P. M.; Batlevi, C. L.; Caron, P. C.; Constine, L. S.; Dandapani, S.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Brentuximab vedotin combined with chemotherapy in patients with newly diagnosed early-stage, unfavorable-risk Hodgkin lymphoma
    Journal Article

    Kumar, A.; Casulo, C.; Advani, R. H.; Budde, E.; Barr, P. M.; Batlevi, C. L.; Caron, P.; Constine, L. S.; Dandapani, S. V.; Drill, E.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • A pilot study of brentuximab vedotin combined with AVD chemotherapy and radiotherapy in patients with newly diagnosed early stage, unfavorable risk Hodgkin lymphoma
    Meeting Abstract

    Kumar, A.; Casulo, C.; Advani, R. H.; Budde, L. E.; Barr, P. M.; Batlevi, C. L.; Caron, P.; Constine, L. S.; Dandapani, S.; Drill, E.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • A pilot study of brentuximab vedotin and AVD chemotherapy followed by 20 Gy involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma
    Meeting Abstract

    Kumar, A.; Casulo, C.; Advani, R. H.; Budde, L.; Barr, P. M.; Batlevi, C. L.; Caron, P.; Chen, R. W.; Constine, L. S.; Courtien, A.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • A pilot study of brentuximab vedotin and AVD chemotherapy followed by 20 Gy involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma
    Meeting Abstract

    Kumar, A.; Casulo, C.; Advani, R.; Budde, E.; Barr, P. M.; Batlevi, C. L.; Chen, R.; Constine, L. S.; Courtien, A. I.; Dandapani, S. V.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save
  • Brentuximab vedotin and AVD followed by involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma
    Journal Article

    Kumar, A.; Casulo, C.; Yahalom, J.; Schòˆder, H.; Barr, P. M.; Caron, P.; Chiu, A.; Constine, L. S.; Drullinsky, P.; Friedberg, J. W.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Safety and early efficacy in an ongoing pilot study of brentuximab vedotin and AVD chemotherapy followed by 30 gray involved-site radiotherapy for newly diagnosed, early stage, unfavorable risk Hodgkin lymphoma
    Meeting Abstract

    Kumar, A.; Yahalom, J.; Schoder, H.; Caron, P.; Drullinsky, P.; Gerecitano, J. F.; Hamilton, A.; Hamlin, P.; Horwitz, S. M.; Jacob, A. G.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • The NHL-15 protocol for aggressive non-Hodgkin's lymphomas: A sequential dose-dense, dose-intense regimen of doxorubicin, vincristine and high-dose cyclophosphamide
    Journal Article

    Portlock, C. S.; Qin, J.; Schaindlin, P.; Roistacher, N.; Myers, J.; Filippa, D.; Louie, D.; Zelenetz, A. D.; O'Brien, J. P.; Moskowitz, C.; more...
    Annals of Oncology (2004)

    Fulltext@MSK | Save
  • Rare variants of ATM and risk for Hodgkin's disease and radiation-associated breast cancers
    Journal Article

    Offit, K.; Gilad, S.; Paglin, S.; Kolachana, P.; Roisman, L. C.; Nafa, K.; Yeugelowitz, V.; Gonzales, M.; Robson, M.; McDermott, D.; more...
    Clinical Cancer Research (2002)

    Fulltext@MSK | Save
  • The impact of the sequence of radiation and chemotherapy on local control after breast-conserving surgery
    Journal Article

    McCormick, B.; Norton, L.; Yao, T. J.; Yahalom, J.; Petrek, J. A.
    The Cancer Journal from Scientific American (1996)

    Fulltext@MSK | Save